Analysts rate ICICI Prudential Life Insurance Company Limited Strong Buy (bullish), based on 33 analysts. Average price target: ₹629.70.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 260 declarations
Nearly the whole record for ICICI Prudential Life Insurance Company Limited, an Indian company classed in finance and listed on the Bombay stock exchange (market capitalisation of INR 635.4 billion, 23.6% held by insiders), dates from 2021: 240 of the 260 filings, against 18 in 2022 and 2 in 2025. There is no purchase.
The 134 sales total EUR 4,661,061, with a median of EUR 10,049, against 67 grants and 59 filings of another kind. The largest amounts are by Anand Desai, EUR 372,727 on May 25, 2021, and by Asha Murali, EUR 359,126 on August 20, 2021 and EUR 303,180 on June 22, 2021. Binoy Thadaparambath has 25 filings, 10 of them sales; Toshit Kumar 22, of which 15 sales; Shubhashish Banerjee 17, of which 16 sales.
Fifty filers appear in the record. Trades run from April 12, 2021 to December 19, 2025. The 2 filings of the last twelve months include one sale. The publication delay is a median of 2 days.